Cover Image
市場調查報告書

子宮頸癌診斷檢驗市場(檢查別:子宮頸部細胞診斷,陰道鏡檢查,微超音波,微PAT) - 全球產業分析,規模,佔有率,成長,趨勢,及未來預測

Cervical Cancer Diagnostic Tests Market (Tests (Pap Smear tests, Colposcopy, HPV Testing, Endocervical Curettage & Others (Cone Biopsy & Loop Electrosurgical Excision Procedure): Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014-2020

出版商 Transparency Market Research 商品編碼 320992
出版日期 內容資訊 英文 85 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
子宮頸癌診斷檢驗市場(檢查別:子宮頸部細胞診斷,陰道鏡檢查,微超音波,微PAT) - 全球產業分析,規模,佔有率,成長,趨勢,及未來預測 Cervical Cancer Diagnostic Tests Market (Tests (Pap Smear tests, Colposcopy, HPV Testing, Endocervical Curettage & Others (Cone Biopsy & Loop Electrosurgical Excision Procedure): Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014-2020
出版日期: 2014年11月27日 內容資訊: 英文 85 Pages
簡介

子宮頸癌是美國最多女性患得的癌症之一。同時也是全球女性第三大癌症,是第二大癌症死亡原因,一年造成30萬人的死亡。

本報告提供全球子宮頸癌診斷檢驗市場相關的總括性調查,為您彙整市場現狀與規模,今後的預測,競爭趨勢,還有主要加入企業簡介等資料。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 簡介
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 市場機會
  • 波特五力分析
  • 市場魅力度分析
  • 熱圖分析

第4章 全球子宮頸癌診斷檢驗市場:檢查別

  • 簡介
  • 子宮頸部細胞診斷
  • 陰道鏡檢查
  • HPV檢驗
  • 子宮頸內刮除術
  • 其他

第5章 各地區市場收益

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第6章 建議

  • 成功策略
    • 為了能參與該國篩檢計劃的取得認證
    • 以亞太地區等新興市場為目標
    • 推銷的強化與對醫護人員的訓練計劃
    • 為求發現創新的解決方案,著重研究開發

第7章 企業簡介

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Quest Diagnostics, Inc.
  • QIAGEN N.V.
  • Femasys, Inc.
  • Zilico Ltd.
  • Guided Therapeutics, Inc.
  • OncoHealth Corp.
  • Smiths Medical
  • Terumo Corporation

圖表

目錄

Cervical cancer is a medical condition in which cells present in the lining of the cervix - gradually develop into pre-cancerous mass of cells that ultimately turn into cancerous tumors. Two major types of cervical cancers that are typically screened and diagnosed in women include adenocarcinoma and squamous cell carcinoma. At the same time, it has been observed that approximately 90% cases of cervical cancers are squamous cell carcinoma. Virtually, almost all the cases of cervical cancer cases are due to specific types of human papillomavirus and there are more than 100 different types of HPV virus present, of which nearly 40 are sexually transmitted. Among these, about 15 different types HPV viruses are considered as high-risk type or cancer causing. Today, cervical cancer is recognized to be one of the most common types of cancers affecting U.S. women and ranks 14th in frequency. Worldwide, cervical cancer is the third most common cancer among women and the second most frequent cause of cancer-related death, accounting for almost 300,000 deaths annually.

This research report provides a detailed analysis of the global cervical cancer diagnostic tests market and helps in understanding the various driving factors for the growth of the market. The market overview section analyzes market dynamics and trends such as drivers, restraints and opportunities that influence the current nature and future status of the market. The executive summary provides detailed insights about the report and the market in general. It also contains a market snapshot, which provides a glimpse into the present scenario of the global cervical cancer diagnostic tests market. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been explained in the market overview section of the report in order to deliver a thorough analysis of the overall competitive scenario of the global cervical cancer diagnostic tests market.

The global cervical cancer diagnostic tests market is segmented based on types of tests performed for the diagnosis of cancer patients. Based on the test types, the market is segmented into Pap smear tests, HPV testing, colposcopy, endocervical curettage procedure and others, which comprise cone biopsy and Loop Electrosurgical Excision Procedure (LEEP). Market size estimates and forecasts for the period 2012 to 2020 have been provided for each of the segments mentioned above in terms of USD million, considering 2013 as the base year for calculating market forecast and 2012 as the historical year. The CAGR (%) of each market segment for the forecast period 2014 to 2020 has also been provided along with market size estimations.

Geographically, the global cervical cancer diagnostic tests market has been segmented into four major regional markets: North America, Europe, Asia Pacific and Rest of World (RoW). The market size estimations and forecasts for the period 2012 to 2020 have been provided for each of these regions at a segment level, in terms of USD million along with the CAGR for the forecast period 2014 to 2020. This study further offers market recommendations for the global cervical cancer diagnostic tests market. These include factors that may play a critical role in enhancing or boosting the market in the near future, as well as steps that need to be considered to ensure success for manufacturers.

The report concludes with the company profiles section and includes key information about the major players who are actively participating in this market. The company profiles included in the report are framed in terms of company overview, financial overview, business strategies, recent developments and product portfolio. Key players profiled in this report include Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics, Inc., QIAGEN N.V., Femasys, Inc., Zilico Ltd., Guided Therapeutics, Inc., OncoHealth Corp.,

Table of Contents

Chapter 1 Introduction

  • 1.1 Report Description
  • 1.2 Research Methodology
  • 1.3 Market Segmentation

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Cervical Cancer Diagnostic Tests Market
  • 2.2 Global Cervical Cancer Diagnostic Tests Market, by Type of Tests, 2013 (USD Million)
  • 2.3 Comparative Analysis: Global Cervical Cancer Diagnostic Tests Market, by Geography, 2013 & 2020 (Value %)

Chapter 3 Market Overview

  • 3.1 Introduction
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers
      • 3.2.1.1 Rising prevalence rate of cervical cancer expected to boost market growth
      • 3.2.1.2 High incidence rate of HPV infections likely to drive the growth of the market
      • 3.2.1.3 Increasing cervical cancer screening awareness programs assisting in accelerating market growth
    • 3.2.1.4 Breakthrough products and technologies likely to fuel the growth of the market
    • 3.2.2 Market Restraints
      • 3.2.2.1 Lack of appropriate primary healthcare infrastructure to impede the growth of the market
      • 3.2.2.2 Low awareness hinders the growth of the market
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Strengthening distribution network in emerging markets
    • 3.3 Porter's Five Forces Analysis
      • 3.3.1 Bargaining Power of Suppliers
      • 3.3.2 Bargaining Power of Buyers
      • 3.3.3 Threat of New Entrants
      • 3.3.4 Threat of Substitutes
      • 3.3.5 Competitive Rivalry
    • 3.4 Market Attractiveness Analysis: Global Cervical Cancer Diagnostic Tests Market, by Geography
    • 3.5 Heat Map Analysis for Cervical Cancer Diagnostic Tests Market, by Key Market Players

Chapter 4 Global Cervical Cancer Diagnostic Tests Market, by Type of Test

  • 4.1 Introduction
    • 4.1.1 Global Cervical Cancer Diagnostic Tests Market Revenue, by Type of Tests, 2012 - 2020 (USD Million)
  • 4.2 Pap Smear Tests
    • 4.2.1 Global Pap Smear Tests Market Revenue, 2012 - 2020 (USD Million)
  • 4.3 Colposcopy
    • 4.3.1 Global Colposcopy Market Revenue, 2012 - 2020 (USD Million)
  • 4.4 HPV Testing
    • 4.4.1 Global HPV Testing Market Revenue, 2012 - 2020 (USD Million)
  • 4.5 Endocervical Curettage (ECC)
    • 4.5.1 Global Endocervical Curettage (ECC) Market Revenue, 2012 - 2020 (USD Million)
  • 4.6 Others [Cone biopsy and Loop Electrosurgical Excision Procedure (LEEP)]
    • 4.6.1 Global Other Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)

Chapter 5 Global Cervical Cancer Diagnostics Tests Market, by Geography

  • 5.1 Overview
    • 5.1.1 Global Cervical Cancer Diagnostic Tests Market Revenue, by Geography, 2012-2020 (USD Million)
  • 5.2 North America
    • 5.2.1 North America Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
  • 5.5 Rest of the World (RoW)
    • 5.5.1 RoW Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)

Chapter 6 Recommendations

  • 6.1 Success Strategies (Key Focus Areas)
    • 6.1.1 Gain Accreditation to Ensure Qualification to Participate in National Screening Programs across the Regions
    • 6.1.2 Target Emerging Markets of Asia Pacific and RoW
    • 6.1.3 Intensify Promotion and Training Programs for Healthcare Professionals
    • 6.1.4 Emphasis on Research and Development to come up with Innovative Solutions

Chapter 7 Company Profiles

  • 7.1 Abbott Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Product Portfolio
    • 7.1.4 Business Strategies
    • 7.1.5 Recent Developments
  • 7.2 Becton, Dickinson and Company
    • 7.2.1 Company Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Product Portfolio
    • 7.2.4 Business Strategies
    • 7.2.5 Recent Developments
  • 7.3 Hologic, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Product Portfolio
    • 7.3.4 Business Strategies
    • 7.3.5 Recent Developments
  • 7.4 F. Hoffmann-La Roche Ltd.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Product Portfolio
    • 7.4.4 Business Strategies
    • 7.4.5 Recent Developments
  • 7.5 Quest Diagnostics, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Product Portfolio
    • 7.5.4 Business Strategies
    • 7.5.5 Recent Developments
  • 7.6 QIAGEN N.V.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Product Portfolio
    • 7.6.4 Business Strategies
    • 7.6.5 Recent Developments
  • 7.7 Femasys, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Overview
    • 7.7.3 Product Portfolio
    • 7.7.4 Business Strategies
    • 7.7.5 Recent Developments
  • 7.8 Zilico Ltd.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Overview
    • 7.8.3 Product Portfolio
    • 7.8.4 Business Strategies
    • 7.8.5 Recent Developments
  • 7.9 Guided Therapeutics, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Overview
    • 7.9.3 Product Portfolio
    • 7.9.4 Business Strategies
    • 7.9.5 Recent Developments
  • 7.10 OncoHealth Corp.
    • 7.10.1 Company Overview
    • 7.10.2 Financial Overview
    • 7.10.3 Product Portfolio
    • 7.10.4 Business Strategies

List of Figures

  • FIG. 1 Global Cervical Cancer Diagnostic Tests Market Segmentation
  • FIG. 1 Global Cervical Cancer Diagnostic Tests Market, by Type of Tests, 2013 (USD Million)
  • FIG. 2 Comparative Analysis: Global Cervical Cancer Diagnostic Tests Market, by Geography, 2013 & 2020 (Value %)
  • FIG. 3 Cervical Cancer Diagnostic Tests Market, Drivers and Restraints
  • FIG. 4 Porter's Five Forces Analysis: Cervical Cancer Diagnostic Tests Market
  • FIG. 5 Market Attractiveness Analysis: Global Cervical Cancer Diagnostic Tests Market, by Geography
  • FIG. 6 Heat Map Analysis of Key Market Players for the Cervical Cancer Diagnostic Tests Market
  • FIG. 7 Global Pap Smear Tests Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 8 Global Colposcopy Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 9 Global HPV Testing Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 10 Global Endocervical Curettage (ECC) Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 11 Global Other Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 12 North America Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 13 Europe Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 14 Asia Pacific Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 15 RoW Cervical Cancer Diagnostic Tests Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 16 Abbott Laboratories: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 17 Becton, Dickinson & Company: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 18 Hologic, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 19 F. Hoffmann-La Roche Ltd.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 20 Quest Diagnostics, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 21 QIAGEN N.V.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 22 Guided Therapeutics, Inc.: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global Cervical Cancer Diagnostic Tests Market
  • TABLE 2 Global Cervical Cancer Diagnostic Tests Market Revenue, by Type of Tests, 2012 - 2020 (USD Million)
  • TABLE 3 Global Cervical Cancer Diagnostic Tests Market Revenue, by Geography, 2012 - 2020 (USD Million)
Back to Top